5
Views
0
CrossRef citations to date
0
Altmetric
Research Article

LITERATURE ALERTS

Pages 535-546 | Published online: 29 Sep 2008

LITERATURE ALERTS

  • %6-Fluoroquinolone-liposom e interactions: fluorescence quenching study using iodide. VAZQUEZ, J. L., MONTERO, M. T., TRIAS, j., and HERNANDEZ-BORRELL, J,, Int. J. Pharm., 1998, 171 (1), 75–86.
  • A poly(D, L-lactide-co-glycolide) m icrosphere depot system for delivery of haloperidol. CHENG, Y. H., ILLuvl, L., and DAVIS, S. S., J. Controlled Release, 1998, 55 (2, 3), 203–212.
  • A new preparation method for protein loaded poly(D, L-lactic, co-glycolic acid) micro-spheres and protein release mechanism study. PARK, T. G., Yon,G L. H., and SUNG, N.Y., J. Controlled Release, 1998, 55 (2, 3), 181–191.
  • A novel approach to biotransform ations in aqueous-organic tw 0-phase systems: enzym ic synthesis of alkyl beta-(D)-glucosides using m icroencapsulated beta-glucosidase. Q., SARNEY, D. B., KHAN, J. A., and VULFSON, E. N., Biotechnol. Bioeng., 1998, 60(3), 385-390. A study of m icroencapsulated chiral nem atics in the presence of electric fields. EVANS, M. K., RAPLEY, C. W., WILCOCK, D. W., and SHELDRAKE, T. H., Int. J. Heat Mass Transfer, 1998, 41 (22), 3685–3687.
  • Accum ulation of protein-loaded long-circulating m icelles and liposom es in subcutaneous Lew is lung carcinom a in mice. WEISSIG, V., WHITEMAN, K. R., and TORCHILIN, V. P., Pharm. Res., 1998, 15 (10), 1552–1556.
  • Activated charcoal m icrocapsules and their applications. CHANDY, T., and SHARMA, C. P., J. Blom ater. Appl., 1998, 13 (2), 128–157.
  • Acute adm inistration of liposom al coenzym e Q10 increases m yocardial tissue levels and improves tolerance to ischem la reperfusion injury. NIISORI, K., Y. - °KO-1,MA, H., CRESTA- NELLO, J. A., and WHITMAN, G., J., J. Surg. Res., 1998, 79 (2), 141–5.
  • Adsorption of chitin derivatives onto liposom es: optim ization of adsorption conditions. MOHED, M., and CHANG, T. M., J. Microencapsul., 1998, 15 (5), 595–607.
  • Advantages of m icroencapsulation as an im m unoprotection method in the transplantation of pancreatic islets. SUN, A. M., Ann. Transplant, 1997, 2 (3), 55–62.
  • Aggregation of dim yristoylphosphatidylglycerol liposom es by hum an plasm a low density lipoprotein. LAURAEUS, S., HOLOPAINEN, J. M., TASKINEN, M. R., KINNUNEN, T., and PAAVO, K. J., Biochem. Biophys. A eta., 1998, 1373 (1), 147–162.
  • Aggregation state of the glycoprotein excreted by pseudoalterom onas antarctica NF3 on a support of phosphatidylcholine liposom es. DE LA MAZA, A., LOPEZ, 0., PARRA, J. L., SABES, M., and GUINEA, J., Langmuir, 1998, 14 (20), 5680–5684.
  • Amine com position influences apparent activity of enzyme in charged film m icrocapsules. PATIL, R. T., and SPEAKER, T, J., J. Microencapsulation, 1998, 15 (6), 739–745.
  • An experim ental model of acute encephalopathy after total body irradiation in the rat: effect of liposom e-entrapped Cu/Zn superoxide dism utase. LAMPROGLOU, I., VI -AGDELENAT, H., BOISSERIE, G., BALLET, F., MAYO, W FESSI, H., PUISIEUX, F., PERDERAU, B., COLAs, L. N., and DELATTRE, J. V., Int. J. Radiat. Oncol., Biol., Phys., 1998, 42 (1), 179–184.
  • An original m ethod for studying in vitro the enzym atic degradation of cross-linked starch m icrospheres. HAMDI, G., PONCHEL, G., and DUCHENE, D., J. Controlled Release, 1998, 55 (2, 3), 193–201.
  • Anom alous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposom es: a 1H-NMR study. MAURER, N., WONG, K. F., HOPE, M. j., and cuLLIs, P. R., Biochem. Biophys. Acta, 1998, 1374 (1, 2), 9–20.
  • Antibody response in the intestinal tract of mice orally immunized with antigen associated with liposom es. w - ATARAI, S., HAN, M., TAN., and Konwisaw, H., J. Vet. Med. Sci., 1998, 60 (9), 1047–1050.
  • Antioxidant activity of berry phenolics on hum an low -density lipoprotein and liposom e oxidation. HEINONEN, I. M., MEYER, A. s., and FRENKEL, E. N., J. Agric. Food Chem., 1998, 46 (10), 4107–4112.
  • Antioxidant activity of 5-am inosalicylic acid against peroxidation of phosphatidylcholine liposom es in the presence of alpha-tocopherol: a synergistic interaction? GONCALVES, E., ALMEIDA, L. m., and DINIS, T. C. P., Free Radical Res., 1998, 29 (1), 53–66.
  • Application of the m icrocapsuled Na dichloroisocyanurate in laundry pow der. Hu, C., HE, Z., Ron. Y., WANG, G., HUA, Y. E., and ZHU, T., Riyong Huazue Gongye, 1997, 4, 13–15.
  • Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model. SONG, C., LASHASETWAR, V., Cur, X., UNDERWOOD, T., and LEVY, R. J., J. Controlled Release, 1998, 54 (2), 201–211.
  • Arterial uptake of biodegradable nanoparticles: effect of surface modifications. LASHASETWAR, V., SONG, C., HUMPHREY, W., SHEDUSKI, R., and LEVY, R. J., J. Pharm. Sci., 1998, 87 (10), 1229–1234.
  • Asialoglycoprotein receptor-m ediated gene transfer using novel galactosylated cationic liposom es. KzwzxwmI, S., V - AMASHITA, F., NISHIKAWA, M., TAKAKURA, Y., and HASHIDA, M., Biochem. Biophys. Res. Commun., 1998, 252 (1), 78–83.
  • Assessm ent of the activity of atovaquone-loaded nanocapsules in the treatm ent of acute and chronic m urine toxopl asm osis. SORDET, F., AUMJAUD, Y., FESSI, H., and DEROUIN, F., Parasite, 1998, 5 (3), 223–229.
  • Association of liposom es containing a soybean-derived sterylglucoside mixture with rat prim ary cultured hepatocytes. SnImIzu, K., M -AITANI, Y., TAKAHASHI, N., TAKAYAMA, K., and NAGAI, T., Biol. Pharm. Bull., 1998, 21 (8), 818-822. beta-Glucuronidase activity following com plex coacervation and spray drying m icroencap-sulation. BURGESS, D. J., and PONSART, S., J. Microencapsul., 1998, 15 (5), 569–579.
  • Bilayer thickness in unilam ellar extruded egg yolk phosphatidylcholine liposom es: a small-angle neutron scattering study. BALGAVY, P., DUBNICKOVA, M., UHRIKOVA, D., YARADAIKIN, S., KISELEV, M., and GORDELIY, V., Acta Phys., Slovaca, 1998, 48 (4), 509–533.
  • Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. FATTAL, E., VAUTHIER, C., AVNIE, I., NAKADA, Y., LAMBERT, G., MALVY, C., and COUVREUR, P. J., J. Controlled Release, 1998, 53 (1, 3), 137–143.
  • Biodistribution and com puted tom ography studies on ioprom ide liposom es. ERDOGAN, S., Oz, A. Y., ERCAN, M. T., AYDIN, K., and HINCAL, A. A. STP Pharma Sci., 1998, 8 (2), 133–137.
  • Biodistribution and turn or localization of Stealth liposom al tum or necrosis factor-alpha in soft tissue sarcom a bearing rats. VAN DER VEEN, A. H., EGGERMONT, A. M. M., SEYNHAEVE, A. L. B., VAN TIEL, S. T., and TEN HAGEN, T. L. M., Int. J. Cancer, 1998, 77 (6), 901–906.
  • Biodistribution, stability, and antiviral effi cacy of liposom e-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatm ent of chronic duck hepatitis B virus infection. Sow, P. N., BROWN, D., SAFFIE, R., SAVAGE, K., MOORE, D., GREGORIADIS, G., and DUSHEIKO, G. M., Hepatology, 1998, 28 (5), 1402–1410.
  • Carrageenan as an anionic polymer for aqueous m icroencapsulation. PATIL, R. T., and SPEAKER, T. J., Drug Delivery, 1998, 5 (3), 179–182.
  • Catalytic properties of galactose oxidase to liposom e-form ing am phiphiles which have m any pendent galactose residues. OHO, K., and KITANO, H., Bioconjug. Chem., 1998, 9 (5), 548–554.
  • Cationic liposom e-m ediated effi cient induction of type I interferons by a low dose of poly Lpoly C in m ouse cell lines. OKAMOTO, S., WATANABE. Y., TAKAKURA, Y., and HASHIDA, M., J. Biochem. (Tokyo), 1998, 124 (2), 697–701.
  • Cationic liposom e systems in gene therapy. MILLER, A. D., Curr. Res. Mol. T her., 1998, 1 (7), 494–503.
  • Characterization and magnetic properties of P (St-co-4VP) metal m icrospheres. WG, Y., FENG, L., and PAN, C. J. Appl. Polym. Sci., 1998, 70 (12), 2307–2312.
  • Characterization and transplantation of agarose m icroencapsulated canine islets of langer-hans. TASHIRO, H., IWATA, H., WARNOCK, G. L,. TAKAGI, T., MACHIDA, H,, IKADA, Y., and Tsup, T., Ann. Transplant, 1997, 2 (3), 33–39.
  • Chest discom fort associated with liposom al am photericin B: report of three cases and review of the literature. JOHNSON, M. D., DREW, R. H,, and PERFECT,, JJR., Pharmacotherapy, 1998, 18 (5), 1053–1061. 50 Refs.
  • Cholesterol phosphate derivatives: synthesis and incorporation into a phosphatase and calcium-sensitive triggered release liposom e. DAvIs, S. C., and Szoxw, F. C. JR., Bioconjugate Chem., 1998, 9 (6), 783–792.
  • Chrom ophore Orientation in Liposom e Mem branes Probed with Flow Dichroism . ARDHAMMAR, M., MIKATI, N., and NORDEN, B., J. Am. Chem. Soc., 1998, 120 (38), 9957–9958.
  • Coatom er, Arflp, and nucleotide are required to bud coat protein com plex I-coated vesicles from large synthetic liposom es. SAG, A., MATSUOKA, K., HAMAMOTO, S., SCHEKMAN, R., and ORCI, L., Proc. Natl. Acad. Sci., USA, 1998, 95 (15), 11199–11204.
  • Corn parative evaluation of the form ulation, characterization, stability, and in vitro release of ioprom id e liposom es, and niosom es. ERDOGAN, S., OZER, A. Y., and HINCAL, A. A., S T P Pharma. Sci., 1998, 8 (2), 127–132.
  • Corn parison of polym erically stabilized PEG-grafted liposom es, and physically adsorbed carboxym ethylchitin and carboxym ethyl/glycolchitin liposom es for biological appli-cations. MOHED, M., and CHANG, T. M., Biomaterials, 1998, 19 (13), 1167–1177.
  • Corn petitive interactions in negatively charged liposom e-polycation-polyanion ternary systems. YAROSLAVOV, A. A., KOULKOV, V. E., YAROSLAVOVA, E. G., IGNATIEV, M. 0., KAHANOV, V. A., and MONGER, F. M., Langmuir, 1980, 14 (21), 5999–6004.
  • Corn plem ent dependent and independent liposom e uptake by peritoneal m acrophages: cholesterol content dependency. HUONG, T. M., HARASHIMA, H., and KIWADA, H., Bio. Pharm. Bull., 1998, 21 (9), 969–973.
  • Corn positional horn ogeneity of liposom al membranes investigated by capillary electrophor-esis. KAWAKAMI, K., NISHIHARA, Y., and HIRANO, K., J. Colloid Interface S ci., 1998, 206 (1), 177–180.
  • Controlled gene delivery by DNA-gelatin nanospheres. TRUONG, L. V. L., AUGUST, J. T., and LEONG, K. W., Hum. Gene. Ther., 1998, 9 (12), 1709–1717.
  • Core shell type m icrospheres. Isnizu, K., and KOHUNSHI K., 1998, 47 (9), 405–410.
  • Correlation of near infrared spectroscopy cerebral blood flow estim ations and m icrosphere quantitations in newborn piglets. GODDARD, F. J., Louis, P. T., RODRIGUEZ, D. L., Dwvis, Y., CONTANT, C. F., and ROLFE, P., Biol. Neonate, 1998, 74 (5), 376–384.
  • Cost-effectiveness analysis com paring liposom al anthracyclines in the treatm ent of AIDS-related Kaposi's sarcoma. BENNETT, C. L., GOLUB, R. M., STINSON, J., AHOULAFIA, D. M., VON ROENN, J., BOGNER, J., GOEBEL, F. D., and STEWART, S., J. Acquired Immune Defic. Syndr. Hum. Retrovirol, 1998, 18 (5), 460–465.
  • Cytotoxic T lym phocytes and antibodies after orthotropic penetrating keratoplasty in rats treated with dichlorom ethylene diphosphonate encapsulated liposom es. VAN DER VEEN, G., BROERSMA, L., VAN ROOIJEN, N., VAN Rij, G., and VAN DER GAAG, R., Curr. Eye. Res., 1998,18 (10), 1018–1026.
  • Degradation and release profile of m icrocapsules made of poly(L- lactic acid-co-L-lysine(Z)). KIDCHOH, T., KIMUARA, S., and imANIsnI, Y., J. Controlled Release, 1998, 54 (3), 283–292.
  • Delivery of MUC1 m ucin peptide by Poly(d, 1-lactic-co-glycolic acid) m icrospheres induces type 1 T helper immune responses. NEWMAN, K. D., SOSNOWSKI, D. L., KWON, G. S., and SAMUEL, J., J. Pharm. Sci., 1998, 87 (11), 1421–1427.
  • Design and developm ent of adjuvant, active nonionic block copolym ers. NEWMAN, M. J., TODD, C. w., and BALUSUHRAMANIAN, M., J. Pharm. Sci., 1998, 87 (11), 1357–1362.
  • Determ ination of encapsulation effi ciency and release rate of ceftazidim e liposom e by UV spectrophotom etry. Luo, Y., SHEN, H., Du-MING, and KONG, D., Zhongguo Kangshengsu Zazhi, 1998, 23 (3), 203–204. 235.
  • Developm ent of liposom al anthracyclines: from basics to clinical applications. GAMZON, A., GOREN, D., COHEN, R., and BARENHOLZ, Y., J. Controlled Release., 1998, 53 (1, 3), 275–279.
  • Developm ent and characterization of buoyant theophylline m icrospheres with near zero order release kinetics. STITHIT, S., Coca, w., and PRICE, J. C., J. Microencapsulation, 1998, 15 (6), 725–737.
  • Direct synthesis of polyester m icrospheres, potential carriers of bioactive com pounds. SLOMKOWSKI, S., SOSNOWSKI, S., GADZINOWSKI, M., PICHOT, C., and ELAISSARI, A., ACS Symp. Ser., 1998, 709 (Tailored Polymeric Materials for Controlled Delivery Systems), 143–153.
  • Dissem mated histoplasm osis successfully treated with liposom al am photericin B following azathioprine therapy in a patient from nonendem ic area. Povsow, F., GARCIA, A. J., DE LAS NIEVES, M. A., VILLws, E., MONTIEL, N. and DEL Asco, A., Eur. J. Clin. Microbiol. Infect. D is., 1998, 17 (5), 357–359.
  • Distribution of free and liposom al cefoxitin in plasm a and peritoneal fluid in a porcine intra-abdom inal sepsis model. Sums, P. N., TIKUISIS, P., ZAMECNIK, J., SOLTES, S., MUSTARD, R. A., and kr -ITTELMAN, M. W., J. Drug. Target, 1998, 5 (5), 353–364.
  • Does the am ount of an antitum or agent entrapped in liposom es influence its tissue distri- bution and cell uptake? SADZUKA, Y., and HIROTA, S., Cancer Lett., 1998, 131 (2), 163–170. Dye-encapsulating liposom es as fluorescence-based oxygen nanosensors. McNwmwsw, K. P., ROSENZWEIG, Z., Anal. Chem., 70 (22), 4853–4859.
  • Dynam ics of electroporation of synthetic liposom es studied using a pore-m ediated reaction, Ag++ Br-.fwdarw.AgBr. CORREA, N. M., and SCHELLY, Z. A., J. Phys. Chem., B., 1998, 102 (46), 9319–9322.
  • Effect of com bined Cyclosporine A and liposom e encapsulated dichlorom ethylene dipho-sphonate on the organisation of the rat thym us: evidence for a role of m acrophages in guiding the post Cyclosporine A thym ic reorganisation. REZZANI, R., RODELLA, L., and BIANCHI, R., Int. J. Immunopharmacol, 1998, 20 (4, 5), 183–192.
  • Effect of liposom e-encapsulated hem oglobin, neo red cells, on hem orrhagic shock. Ususw, A., OSUKA, F., KIMURA, T., SATO, R., OGATA, Y., GOTOH, H., KIMURA, T., and FUKUI, H., Surg. Today, 1998, 28 (10), 1027–1035.
  • Effect of gas-containing m icrospheres and echo contrast agents on free radical form ation by ultrasound. KoNoo, T., Misis, V., and RIESZ, P., Free Radic. Biol. Med., 25 (4, 5), 605–612.
  • Effect of liposom e-carried prostaglandin El on lipid peroxide in tourniquet shock rats. Zuz,su, J. Y., Zhongguo Bin gli Shengli Zazhi, 1997, 13 (6), 651–654.
  • Effect of saturated/unsaturated phosphatidylcholine ratio on the stability of liposom e-encap-sulated hem oglobin. HUANG, Y, Y., CHUNG, T. W., and Wu, C. I., Int. J. Pharm., 1998, 172 (1, 2), 161–167.
  • Effect of drug-polymer interaction on the release characteristics of m ethacrylic acid copolym er m icrocapsules containing theophylline. HsIGE, G, H., LIAo, C. M., and LIN, S. Y., Artif. Organs, 1998, 22 (8), 651–656.
  • Effect of factors on encapsulation of cisplatin by liposom e. YUN, S. H., and Km., J. m., Choson Minjujuui Immin Konghwaguk Kwahagwon Tongbo, 1998, (2), 45–47.
  • Effect of free and liposom ized albendazole on the immune responses in healthy and Toxocara canis-infected mice. BoxoslcovA, Z., DVOROZNAKOVA, E., DUBINSKY, P., VELEBNY, S., TOMASOVICOVA, 0., and MACHNICKA, B., Vet. Med. (Prague), 1998, 43 (10), 293–300.
  • Effective treatm ent of early endobronchial cancer with regional ad m inistration of liposom e-p53 complexes. Zou, Y., ZoNG, G., LING, Y. H., HAo, M. M., LozANo, G., HONG, W. K., and PEREZ, S. R., J. Natl. Cancer Inst., 1998, 90 (15) 1130–1136.
  • Effects of an agonist, allosteric modulator, and antagonist on guanosine-gam m a-(35S) thiotriphosphate binding to liposom es with varying m uscarinic receptor/Go protein stoichiom etry. JAKUBIK, j., HAGS, T., and TUCEK, S., Mol. Pharmacol. 1998, 54 (5), 899–906.
  • Effects of godulbaegi extracts on the stability and fluidity of phospholipid liposom al m em - branes. Bs, S. J., Ron, S. B., and JUNG, B. M., Han'guk Sikp'um Y ongyang Kwahak Hoechi, 1998, 27 (3) 508–517.
  • Effects of liposom e-encapsulated drugs on m acrophages: coin parative activity of the diam dine 4',6-diam idino-2-phenylindole and the phenanthridinium salts ethidium bromide and propidium iodide. BAKKER, J., SANDERS, A., and VAN ROOIJEN, N., Biochem. Biophys. A cta., 1998, 1373 (1), 93–100.
  • Effects of new triphenylethylene platinum (II) corn plexes on the interaction with phosphati-dylcholine liposom es. GRENIER, G,, BERUBE, G., and GICQUAUD, C., Chem. Pharm. Bull., 46 (9), 1480-1483.
  • Effects of preparation conditions on the m onodispersit) of album in m icrospheres. EL MAIID17, M., IBRAHIM, E. S., SAFWAT, S., EL SA-1,0, A., OFISHIMA, H., MAKINO, K., MURAMATSU, N., and KONDO, T., J. Microencapsul., 1998, 15 (5), 661–673.
  • Electroless deposition copper on polystyrene m icrospheres surface. WANG, W., GUO, H., Gwo, j., and WANG, H., Huagong Jinzhan, 1998, 17 (4), 38–41.
  • Emulsification and microencapsulation properties of gum arable. McNABAEE, B. F., O'RIORDAN, E. D., and O'SULLIVAN, M., J. Agric. Food Chem., 1998, 46 (11), 4551–4555.
  • Endothelial cell activation by leukocyte m icroparticles. MESRI, M., and ALTER, D. C., J. Immunol., 1998, 161 (8), 4382–4387.
  • Energy-filtered cryotransm ission electron m icroscopy of liposom es prepared from hum an stratum corn eum lipids. SCHMIDTGEN, M. C., DRECHSLER, M., LASCH, j, and SCHUBERT, R., J. Microsc. (Oxford), 1998, 191 (2), 177–186.
  • Enhanced antitum or effect of liposom al daunorubicin using antibody-phospholipase C con-jugates or fusion protein. CARTER, G., WHITE, P. FERNIE, M., KING, S., MCLEAN, G., TITBALL, R., and CARE, F. J., Int. J. Oncol., 1998, 13 (4), 819–825.
  • Enhanced gene transfer into HuH-7 cells and prim ary rat hepatocytes using targeted liposom es and polyethylenim inBANOVORA0111,1,, P., KREN, B. T., MA, X., and STEER,C, J., Biotechniques, 1998, 25 (2), 282–284. 286–292.
  • Enhancem ent of m urine host defense function and inhibition of turn or growth by polyphase liposom e encapsulated ginseng polysaccharide. Gu, X., JIANG, C., GU, M., WANG, j., and GAO, Y., Shenyang Yaoke Daxue Xuebao, 1997, 14 (4), 250–253.
  • Entrapm ent of water-soluble core m aterial into biodegradable m icrocapsules prepared by W/O/W em ulsion solvent evaporation. KIVOYAMA, S., SHIOMORI, K., KAWANO, Y., and HATATE, Y., Kagaku Kogaku Ronbunshu, 1998, 24 (5), 791–796.
  • EPR study of m ucoadhesive ointm ents for delivery of liposom es into the oral m ucosa. PETELIN, M., SENTJURC, M., STOLIC, Z., and SKALERIC, U., Int. J. Pharm., 1998. 173 (1, 2), 193–202.
  • Establishm ent of m icrosphere im m unoadsorption experim ental research on adsorptive rate of antibody. MA, Y., WANG, C., MA, J., TANG, Z., and jIxxo, s., Guangxi Shifan Daxue Xuebao, Ziran Kexueban, 1997, 15 (3), 67–71.
  • Evaluation of the hem odynam ic effects of turn or necrosis factor alpha factor in rats with portal hypertension using the radioactive m icrosphere technique. PEREZ, P. M., MUNOZ, J., ALBILLos, A., Ross, I., ALVAREZ, M. M., and ORTIZ, B. J., Rev. Esp. Med. Nucl., 1998, 17(4), 294–301.
  • Experim en tat and clinical evaluation of cisplatin-containing m icrospheres as intraperitoneal chemotherapy for ovarian cancer. SUGIYAMA, T., KUMAGAI, S., NISHIDA, T., USHIJIMA, K., MATSU°, T., YAKUSHIJI, M., HYON, S. H., and IKADA, Y., Anticancer Res., 1998, 18 (4B), 2837–2842.
  • Experim ental studies on thrombolysis adjuvant therapy with liposom e-encapsulated prosta-glandin El and taurine. LI, X., ZHANG, L., GONG, Y., and TANG, C., Zhongguo Yaolixue Tongbao, 1998, 14 (3), 214–216.
  • Experim ental study on release rate of NaCl/EC m icrocapsules. Tu, Y., Nu, Y., Wu, Z., and Znu, Y., Huaxue Yanjiu Yu Y ingyong, 1998, 10 (2), 138–143.
  • Expression of the hum an dystrophin gene in m dx mouse muscle after transfer with liposom es or synthetic oligopeptide com plex vectors. BARANOV, V. S., TARASENKO, 0. V., BARANOV, A. N., KISELEV, A. V., IvwsncnExxo, T. E., EVGRAFOV, 0. V., MIxnmov, V. M., and DICKSON, G., Russ. J. Genet, 1998, 34 (7), 721–726.
  • Expression of the hum an dystrophin gene in m dx mouse muscle fibers after transfection using liposom es and synthetic oligopeptides. BARANOV, V. S., TARASENKO, 0. V., BARANOV, V. S., TARASENKO, 0. V., BARANOV, A. N., KISELEV, A. V., IVASHCHENKO, T. E., EVGRAFOV, 0. V., MIKHAILOV, VM., and DICKSON, G., Genetika, 1998 34 (7), 876–882.
  • Expression of vascular endothelial growth factor gene mediated by lipofect AMINE liposom e in CHO cells. HE, T., QIAN, H., CHEN, S., and ZHANG, B., Shanghai Dier Y ike Daxue Xuebao, 1998, 18 (2), 93–96.
  • Fluorescent solution m icrocapsules as ideal tracer particles in long-term tracking of 3-D Lagrangian trajectories. TAJImw, T., NAKAMURA, T., AZUMA, T., and KUROSAWA, K., Exp. Fluids, 1998, 25 (3), 276–279.
  • Fusigenic Sendai-virus liposom es: a novel hybrid type liposom e for gene therapy. KANEDA, Y., Biog. Amines, 14 (5), 553–572.
  • Gene delivery by negatively charged ternary com plexes of DNA, cationic liposom es and transferrin or fusigenic peptides. SIMOES, S., SLEPUSIIKIN, V., GASPAR, R., DE LIMA, M. c., and DUZGUNECS, N., Gene. T her., 1998, 5 (7), 955–964.
  • Growth inhibition of experim ental gliom a by hum an interferon-beta superinduced by cationic liposom es entrapping polyinosilic:polycytidilic acid. BUCUR, N., MIZUNO, M., WAKABAYASHI, T., and YOSHIDA, J., Neurol. Med. Chir. (Tokyo), 1998, 38 (8), 469–473; discussion 473–474.
  • HindIII liposom es suppress delayed-type hypersensitivity responses in vivo and induce epiderm al IL-10 in vitro. NISHIGORI, C., YAROSH, D., O'CONNOR, A, SHREEDHAR, V. K ULLEIcn, S. E., Cox, P., and KRIPKE, M. L., 1998, J. Immunol., 161 (6), 2684–2691.
  • Host-guest molecule interaction mechanism of hem ostatics with liposom es and red blood cells studied with fluorescence polarim etric method. DU, M., TANG, B., SHENG, H., WANG, S., SUN, T., and ZHANG, C., Yaoxue X uebao, 1998, 33 (5), 362–368.
  • Hydrophobically driven attachm ents of synthetic polym ers onto surfaces of biological interest: lipid bilayers and globular proteins. TRIBET, C., Biochimie, 1998, 80 (5, 6), 461–473. 65 Refs.
  • Impact of liposom es as delivery systems in veterinary medicine. SALLOVITZ, J. M., ZONCO, M. M. I., and LANUSSE, C. E., Vet. Res., 1998, 29 (5), 409–430. 115 Refs.
  • Improvement of pharm acokinetics and antitum or activity against hum an hepatom a cell line by using adriam ycin-entrapped stealth liposom es. SnImIzu, H., Keio Igaku, 1998, 75 (4), T227—T236.
  • In vivo characteristics of injectable poly(DL-lactic acid) m icrospheres for long-acting drug delivery. KOBAYASHI, D., TSUBUKU, S., YAMANAKA, H., ASANO, M., MIYAJIMA, M., and YOSHIDA, M., Drug Dev. Ind. Pharm., 1998, 24 (9), 819–825.
  • In vitro characterization of polyethylene glycol calcium citrate m icrospheres as a delivery system for the study of reparative dentinogenesis. HUNTER, A. R., KIRK, E. E. J., ROBINSON, D. H., and KARDOS, T. B., Endod Dent Traumatol, 1998, 14 (4), 159–162.
  • Increase in phospholipase A2 activity tow ards lipopolym er-containing liposom es. VERMEHREN, C., KIEBLER, T., HYLANDER, I., CALLISEN, T. H., and JORGENSEN, K., Biochim. B iophys. A cta, 1998, 1373 (1), 27–36
  • Induction of nitric oxide production and tum oricidal properties in m urine m acrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposom es. EuE, I., KUMAR, R., DONG, Z., KILLION, J. j., and FIDLER, I, j., J. Immunother., 1998, 21 (5), 340–351.
  • Induction of protection against oral infection with cytotoxin-producing Escherichia coli 0 157:H7 in mice by shiga-like toxin-liposom e conjugate. FUKUDA, T., KIMIYA, T., TAKAHA-SHI, M., ARAKAWA, Y., Am, Y., SUZAKI, Y., NAITO, S., HORINO, A., NAGATA, N., SATOH, S., GoNownaw, F., SUGIYAMA, J., IcHI, N. Y., and MORI, M., Int. Arch. Allergy Immunol., 1998, 116 (4), 313–317.
  • Influence of glutaraldehyde on drug release and m ucoadhesive properties of chitosan m icrospheres. GENTA, I., CONSTANTINI, M., AST, A., CONTI, B., and M —ONTANARI, L., Carbohydr. Polym., 1998, 36 (2/3), 81–88.
  • Influence of liposom al formulation parameters on the in vitro absorption of methyl nico-tin ate. ESPOSITO, E., ZANELLA, C., CORTESI, R., MENEGATTI, E., and NASTRUZZI, C., Int. J. Pharm., 1998, 172 (1, 2), 255–260.
  • Influence of the level of ceram ides in the perm eability of stratum corneum lipid liposom es caused by sodium dodecyl sulfate. DE LA MAZA, A., LOPEZ, 0., COCERA, M., CODERCH, L., and PARRA, J. L., Chem. Phys. Lipids, 1998, 94 (2), 181–191.
  • Influence of shaking and surfactants on the release of BSA from plga m icrospheres. HERNADEZ, R. M., IGARTUA, M., GASCON, A. R., CALVO, M. B,, and PEDRAZ, J, L., Eur. J. Drug. Metab. Pharmacokinet, 1998, 23 (2), 92–96.
  • Influence of additives on the release profile of nifedipine from poly (DL-lactide-co-glycolide) m icrospheres. S ANSDRAP, P., and Moos, A, J., J. Microencapsul., 1998, 15 (5), 545–553.
  • Inhibiting effect of vitam in E and C on peroxidation of soybean liposom aim em branes. Mo, F., Znu, C., HUANG, s., and xu, j., Zhongguo Yaowu Huazue Zazhi, 1997, 7 (2), 121–124.
  • Inhibition of liposom e-induced com plem ent activation by incorporated polyethylene glycol-lipids. BRADLEY, A. J., DEVINE, D. V., ANSELL, S. M., JANZEN, j., and BROOKS, D. E., Arch. Biochem. Biophys., 1998, 357 (2), 185–194.
  • Interaction between isolated and purified liver cells and small unilam ellar liposom es. DINT, L., FALAscw, L., Ruzz.-ru, M. T., Mossw, G., FINAZZI, A. A., and Dr GIu.o, A., Liver., 1998 18 (4), 229–238.
  • Interaction between PC12 liposom es encapsulating ATP and hum an sperm atozoa. SNI.N, L., SKISAL, M., NIKAS, G., AUGER, J., FATTAL, E., DELATTRES, j., and COURTOT, A. M., Int. J. Pharm., 1998, 172 (1-2), 147–159.
  • Interaction of saccharides with lipid membrane relating to the freeze-drying of liposom e. MIYAJIMA, K., Maku, 1998, 23 (6), 288–293.
  • Interaction of doxorubicin with AT quantification of com plexes and effect on its diffusion into DNA, loaded liposom es-im plication for ATP-driven transport studies. CHAMBON, M. H., and VIRATELLE, 0. M., Anal. Biochem., 1998, 263 (2), 198–207.
  • Interfacial indazolization: novel chem ical evidence for rem arkably high exo-surface pH of cationic liposom es used in gene transfection. BANERJEE, R., Dws, P. K., and CHAUDHURI, A., Biochem. Biophys. A cta, 1998, 1373 (2), 299–308.
  • Intracellular regulation of macromolecules using pH-sensitive liposom es and nuclear localization signal: qualitative and quantitative evaluation of intracellular trafficking. TACHISANA, R., HwowsnImw, H., Snoxo, M., AZUMANO, M., NIWA, M., FUTAKI, s., and KIWADA, H., Biochem. Biophys. Res. Commun., 1998, 251 (2), 538–544.
  • Intracellular delivery and antibacterial activity of gentam icin encapsulated in pH-sensitive liposom es. LUTWYCHE, P., CORDEIRO, C., WISEMAN, D. J., Sr LOUIS, M. U., MITCHELL, H. M. J., WERE, M. S., and FINLAY, B. B., Antimicrob Agents Chemother, 1998, 42 (10) 2511–2520.
  • Intraoperative and postoperative kinetics of serum tum or m arkers in patients with oral carcinoma. HOFFMANN, J., MUNZ, A., KRINIMEL, M., and ALFTER, G., J. Oral Maxillofac. Surg., 1998, 56 (12), 1390–1393.
  • Intratum oral injection of rhenium -188 m icrospheres into an anim al model of he patom a. L. H., TswI, Z. T., TING, G, MIRZADEH, s, and KNAPP, F. F. Jo., J. Nucl. Med., 1998, 39 (10), 1752–1757.
  • Investigation of lipid peroxidation in liposom es induced by heavy ion irradiation. ZIEGLER, C., and w - ESSELS, J. M., Radiat. Environ. Biophys., 1998, 37 (2), 95–100.
  • Isolated cerebral aspergillosis without a portal of entry-complete recovery after liposom al am photericin B and surgical treatm ent. GARCIA, A., MAZUECOS, A., CLAY°, A., PEREZ, R. J., MANGAS, A., ALONSO, F., CESALLOS, M., and RIVER°, M., Nephrol. Dial. Transplant, 1998, 13 (9), 2385–2387.
  • Isotype profiles of Leishm ania donovani, infected BALB/c mice: preferential stim ulation of IgG2a/b by liposom e-associated prom astigote antigens. AFRIN, F., and ALT, N., J. Para-sitol., 1998, 84 (4), 743–748.
  • Kinetic analysis of the interaction between liposom es and the com plem ent system in rat serum: re-evaluation of size-dependency. v - AMADA, M., HARASHIMA, H., and KIwwpw, H., Biol. Pharm. Bull., 1998, 21 (9), 964–968.
  • Lim ited use of cationic liposom es as tools to enhance the antiherpetic activities of oligo-nucleotides in Vero cells infected with herpes sim plex virus type 1. SHOJI, Y., NORIMATSU, M., SHIMADA, j., and mIzusnImA, Y., A ntisense Nucleic Drug Dev., 1998, 8 (4), 255–263.
  • Lipid-drug interaction: therm odynam ic and structural effects of antim ycotic fluconazole on DPPC liposom es. AXIBROSINI, A., BossI, G., DANTE, S., DUSINI, B., GOBBI, L., LEONE, L., GRAZIA, P. B. M., and ZOLESE, G., Chem. Phys. Lipids, 1998, 95 (1), 37–47.
  • Liposom al form ulations for oral im m unotherapy: in -vitro stability in synthetic intestinal media and in -vivo effi cacy in the mouse. OuwownI, S., PATERNOSTRE, M., ANDRE, C., GENIN, I., THAO, T. X., PUISIEUX, F., DEVISSAGUET, J. P., and BARRATT, G., J. Drug. Target, 1998, 5 (5), 365–378.
  • Liposom al vincristine for the treatm ent of hum an acute lym phoblastic leukemia in severe corn bined im m unodeficient (SCID) mice. MILLAR, J. L., MILLAR, B. C., PowLEs, R. L., STEELE, J. P. C., CLUTTERSUCK, R. D., MITCHELL, P. L. R., Cox, G., FORSSEN, E., and CATOVSKY, D., Br. J. Haematol, 1998, 102 (3), 718–721.
  • Liposom al tacrolim us and intestinal drug concentration. D and MCALISTER, V. C., Transplant Proc., 1998, 30 (6), 2651–2652.
  • Liposom e effect on the cytochrom e c-catalyzed peroxidation of carbonyl substrates to triplet species. NANTES, I. L., FALJONI, A. A, VERCESI, A. E., SANTOS, K. E., and BECHARA, E, J., Free Radic. Biol. Med., 1998, 25 (4, 5), 546–553.
  • Liposom e encapsulated prostaglandin El in erectile dysfunction: correlation between in vitro delivery through foreskin and effi cacy in patients. FOLDVARI, M., OGUEJI0FOR, C., AFRIDI, S., KUDEL, T., and WILSON, T., Urology, 1998, 52 (5), 838–843.
  • Liposom e im m unoassay by long-lived fluorescence detection. OKADA-1,51H, Y., and IKEUCHI, Analyst, 1998, 123 (6), 1329–1332.
  • Liposom e-anchored vascular endothelial growth factor aptam ers. WILLIS, M. C., COLLINS, B., ZHANG, T., GREEN, L. S., SEDESTA, D. P., BELL, C., KELLOGG, E., GILL, S. C., MAGALLANEZ, A., KNAUER, S., BENDELE, R. A., GILL, P. S., and jANtIe, N., Bioconjug. Chem., 1998, 9(5), 573–582.
  • Liposom e-m ediated transfection of fetal lung epithelial cells. DNA degradation and enhanced superoxide toxicity. TANSWELL, A. K., STAGE, 0., ILES, R., BELCASTRO, R., CABACUNGAN, J., SEDLACKOVA, L., STEER, B., WEN, Y., Hu, j., and O'BRODOVICH, H., Am. J. Physiol, 1998, 275 (3, Pt. 1), L452–L460.
  • Liposom es as drug delivery system: a strategic approach for the treatment of HIV infection. DESORMEAUX, A., and BERGERON, M. G., J. Drug Target, 1998, 6 (1), 1–15. 105 Refs.
  • Liposom es dispersed within a therm °sensitive gel: a new dosage form for ocular delivery of oligonucleotid es. BOCHOT, A., FATTAL, E., GULIK, A., COUARRAZE, G., and COUVREUR, P., Pharm. Res., 1998, 15 (9), 1364–1369.
  • Liposom es in gene therapy. Structural polym orphism of lipids and effectiveness of gene delivery. TARAHOVSKY, Y. S., IVANITS10,, and G, R., Biochemistry (Moscow), 1998, 63 (6), 607–618.
  • Liposom es and polym ers. LASIC, D. D., Polym. News, 1998, 23 (11), 367–375.
  • Loading of doxorubicin into liposom es by form ing Mn2+ -drug com plexes. CHEUNG, B. C., SUN, T. H., LEENHOUTS, J. M., and CuLL1s, P. R., Biochim. Biophys. Acta., 1998, 1414 (1, 2), 205–216.
  • Local rem oval of phagocytic synovial lining cells by clodronate- liposom es decreases cartilage destruction during collagen type II arthritis. VAN LENT, P. L. HOLTHUYSEN, A. E., VAN RooIJEN, N., VAN DE PUTTE, L. B., and VAN DEN BERG, W., B. Ann. Rheum. Dis., 1998, 57 (7), 408–413.
  • Location of flu orotryptoph an sequestered in an am ph iph ilic nanoparticle by rotational-echo double-resonance NMR. BAUGHER, A. H., GOETZ, J. M., MCDOWELL, L. M., HUANG, H. WOOLEV, K. L., and SCHAEFER, J. Biophys. J., 1998, 75 (5), 2574–2576.
  • Mechanisms of liposom es/w ater partitioning of (p-m ethylbenzyl) alkylam Ines. FRUTTERO, R. CARON, G., FORNATTO, E., BoscnI, D., ERIVIONDI, G., GAsco, A., CARRUPT, P. A., and TESTA, B. Pharm. Res., 1998, 15 (9), 1407–1413.
  • Methotrexate loaded chitosan and chitin m icrospheres-in vitro characterization and phar-m acokinetics in mice bearing Ehrlich ascites carcinoma. SINGH, U. v., and UDUPA, N., J. Microencapsul., 1998, 15 (5), 581–594.
  • Microcalorim etric study on the phase behaviour of S-layer coated liposom es. KUPCU, S., LOHNER, K., MADER, C., and SLEXTR, U, B., Mol. Membr. Biol., 1998, 15 (2), 69–74.
  • Microcapsules. TANAKA, M., Shikizai Kyokaishi, 1998, 71 (9), 593–598.
  • Microencapsulated ferrous sulfate to fortify cow milk: absorption and distribution in mice. floc.o, J. R., ZUHILLAGA, M. B., CARO, R. A., LYSIONEK, A. E., SALGUEIRO, M. J., CALIVIANOVICI, G. P., SARAHIA, M. I., and w.Itt, R., J. Nutr. S ci. Vitaminol (Tokyo), 1998, 44 (3), 381–389.
  • Microencapsulated fire retardants in polym ers. ANTONOV, A., POTAPOVA, E., RUDAKOVA, T., RESHETNIKOV, I., ZusxovA, N., Tucwrrovw, m., and KHALTURINSKIJ, N., Spec. Publ. R. Soc. Chem., 1998, 224 (Fire Retardancy of Polymers), 290–303.
  • Microencapsulation of islets and model beads with a thin alginate-Ba2+ gel layer using centrifugation. PARK, Y. G., IWATA, H, and IKADA, Y., Polym. Adv. Technol., 1998, 9 (10, 11), 734–739.
  • Microencapsulation of islets in PEG-am me modified alginate-poly(L-lysine)-alginate micro-capsules for constructing bioartificial pancreas. Cn.N, J. P., CHU, I. M., SHIAO, M. Y., Hsu, B. R. S., and Fu, S. H., J. Ferment Bioeng., 1998, 86 (2), 185–190.
  • Microencapsulation of rhizobacteria by spray-drying: form ulation and survival studies. C. C., GADILLE, P., DIGAT, B., and BENOIT, J. P., J. Microencapsul., 1998,15 (5), 639-659. Microencapsulation in yeast cells. BISHOP, J, R. P., NELSON, G., and LAms, J., J. Microencapsula-tion, 1998, 15 (6), 761–773.
  • Microen capsulation. SPARKS, R. E., Jwcoss, I. C., and MASON, N. S., Drug Manuf. Technol. Ser., 1999, 3, 177–222.
  • Microencapsulation: a review of polym ers and technologies with a focus on bioartificial organs. RENKEN, A., and HUNKELER, D., Polimery (Warsaw), 1998, 43 (9), 530–539.
  • Microsphere em holism -induced changes in noradrenaline uptake of the cerebral cortex in rats. HAYASHI, H., HIROTA, S., and TAKEO, S., Brain Res., 1998, 808 (2), 190–196.
  • Microsphere infusion reverses vasoconstrictor-m ediated change in hindlimb oxygen uptake and energy status. VINCENT, M. A., RATTIGAN, S., and CLARK, M. G., Acta. Physiol. Scand., 1998, 164 (1), 61–69.
  • Modulation of annexin VI-driven aggregation of phosphatidylserine liposom es by ATP. BANDOROWICZ, P. j., and P - IKULA, S., Biochimie., 1998, 80 (7), 613–620.
  • Mucoadhesive m icrospheres containing am oxicillin for clearance of Helicobacter pylori. NAGAHARA, N., AKIYAMA, Y., NAKAO, M., TADA, M., KITANO, M., and 0GAWA, Y., Antimicrob Agents Chem other., 1998, 42 (10), 2492–2494.
  • Multivesicular liposom e (DepoFoam ) technology for the sustained delivery of insulin-like growth factor-I (IGF-I). KATRE, N. V., ASHERMAN, J., SCHAEFER, H., and Ho, M., J. Pharm. Sci., 1998, 87 (11), 1341–1346.
  • Nanoparticle technology for delivery of drugs across the blood-brain barrier. SCHROEDER, U., SOMMERFELD, P., UlAucn, S., and sA.EL, B. A., J. Pharm. S ci., 1998, 87 (11), 1305–1307.
  • Natural convection heat transfer from a heated horizontal cylinder with m icroencapsulated phase-change-m aterial slurries. Kurt°, S., AKINO, N., TANAKA, A., and NAGASHIMA, A., Nippon Kikai Gakkai Ronbunshu, B-hen., 1998, 64 (625), 3013–3020.
  • NMR relaxom etric investigations of solid lipid nanoparticles (SLN) containing gadolinium (III) com plexes. MOREL, S., TERRENO, E., UGAZIO, E., AIME, S., and GASCO, M. R., Eur. J. Pharm. Biopharm., 1998, 45 (2), 157–163.
  • Novel m ucosal im m unization with polysaccharide-protein conjugates entrapped in alginate m icrospheres. CHO, N. H., SEONG, S. Y., CHUN, K. H., Ku, Y. H., KWON, I. C., Ann, B. Y., and JOG, S. Y., J. Controlled Release, 1998, 53 (1, 3), 215–224.
  • On the efficacy of free, and liposom al forms of platinum and anthracycline antibiotics for hepatic metastasis of GA-1 and P-388 tum ors in mice. KALEDIN, V. I., and ILNITSKAYA, S. I., Vopr. Onkol., 1996, 42 (3), 64–66.
  • On the possibility of instability of high-power laser field in low -Q dielectric m icrosphere: theory and sim ulation. GRUZDEV, V., LIBENSON, M., and GRUZDEVA, A., Conf. Proc. Ital. Phys. Soc., 61 (Advances in Computational Materials Science, II), 1998, 95, 101.
  • Optimal construction of im m unom agnetic m icrospheres by 1251, labeled antibody methods. KG, J., SANTEM, B., HE, S., XIE, S., and WEI, S., Zhongguo Yaoxue Zazhi (Beijing), 1998, 33 (3), 148–151.
  • Organized silica m icrospheres carrying ferrom agnetic cobalt nanoparticles as a basis for tip arrays in magnetic force microscopy. RAMESH, S., COHEN, Y., PROZOROV, R., SHAFI-KURIKKA, V. P. M., AURHACK, D., and GEDANKEN, A., J. Phys. Chem. B., 1998, 102 (50), 10234–10242.
  • Ovalbum in peptide encapsulated in poly(d, 1 lactic-co-glycolic acid) m icrospheres is capable of inducing a T helper type 1 immune response. NEWMAN, K. D., SAMUEL, j, and KWON, G., J. Controlled Release, 1998, 54 (1), 49–59.
  • Param eters affecting in-liquid drying m icroencapsulation and release rate of cefaclor. CHOW, A. H. L., Ho, S. S. S., TONG, H. H. Y., and MA, H. H, M., Int. J. Pharm., 1998, 172 (1, 2), 113–125.
  • Perm eability changes in liposom es modeling the stratum corneum lipid com position due to C12-alkyl betaine/sodium dodecyl sulfate mixtures. DE LA MAZA, A., LOPEZ, 0., CODERCH, L., and PARRA, J. L., Int. J. Pharm., 1998, 171 (1), 63–74.
  • PH-sensitive liposom es for receptor-m ediated delivery to chicken hepatom a (LMH) cells. SKALKO, N., PESCHKA, R., ALTENSCHMIDT, A., LUNG, A., and SCHUBERT, R., FEBS Lett., 1998, 434 (3), 351–356.
  • Pham acokinetics and distribution of liposom al busulfan in the rat. A new form ulation for intravenous adm inistration. HASSAN, M., HASSAN, Z., NILSSON, C., REHIM, M., ADDEL, K. S., ELFSSON, B., and KAALLBERG, N., Cancer Chemother Pharamcol., 1998, 42 (6) 471–478.
  • Pharm acokinetics of retinoic acid adm inistered as single intravenous liposom al doses in the rat. LEUCUTA, S. E., POPOVICI, M., TOADER, S., Rusu, A., and PORUTIU, D., Clujul. Med., 1997, 70 (4), 684–655.
  • Pharm acokinetics and distribution of liposom al busulfan in the rat: a new form ulation for intravenous administration. HASSAN, M., HASSAN, Z,. NILSSON, C., REHIM, M. A., KUMLIEN, S., ELFSSON, B., and KALLBERG, N., Cancer Chemother. Pharmacol., 1998, 42 (6), 471–478.
  • Pharm acological study on the streptom ycin sulfate gelatin m icrosphere lung-targeting delivery system. YANG, Y., Bo, D,, ZENG, Z., HE, X., and Lu, B., Zhongguo Kangshengsu Zazhi, 1998, 23 (3) 205–208.
  • Phase II trial of liposom al daunorubicin in the treatm ent of AIDS-related pulm onary Kaposi's sarcom a. TULPULE, A., YuNG, R. C., WERNZ, J., EsmNA, B. M., MYERS, A., SCADDEN, D. T., CABRIALES, S., ILAW, M., BOSWELL, W., and GILL, P. S., J. Clin. Oncol. 1998, 16 (10), 3369–3374.
  • Physical properties and pharm acological activity in vitro and in vivo of optim ised liposom es prepared from a new cancerostatic alkylphospholipid. ZEISIG, R., ARNDT, D., STAHN, R., and FICHTNER, I., Biochim. Biophys. Acta., 1998, 1414 (1, 2), 238–248.
  • Physicochem ical characteristics of pentam idine-loaded polym ethacrylate nanoparticles: implication in the intracellular drug release in Leishm ania major infected mice. PAUL, M., DURAND, R., BOULARD, Y., FUSAI, T., FERNANDEZ, C., RIVOLLET, D., DENIAU, M., and ASTIER, A., J. Drug Target., 1998, 5 (6), 481–490.
  • Physicochem ical properties of ligustrazine hydrochloride m icrospheres. ZENG, F. B., Lu, B., and YANG, H., Zhongguo Y iyao Gongye Zazhi, 1998, 29 (8), 354–359.
  • Physicochem ical stability of liposom es. WANG, C., and SUN, D., Zhongguo Yaoxue Zazhi (Beijing), 1998, 33 (2), 65–68.
  • Plasm a protein adsorption on biodegradable m icrospheres consisting of poly(D, L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolym ers containing poly(oxyethylene). Influence of production method and polymer com position. Luc., M., PISTEL, K. F., LI, Y. X., BLUNK, T., MULLER, R. H., and KISSEL, T., J. Controlled Release., 1998, 55 (2, 3), 107–120.
  • Polym eric nanoparticles as delivery system for influenza virus glycoproteins. LEMOINE, D., and PREAT, V., J. Controlled Release, 1998, 54 (1), 15–27.
  • Polyorganophosphazene m icrospheres for drug release: polymer synthesis, m icrosphere preparation, in vitro and in vivo naproxen release. VERONESE, F. M., MARSILIO, F., CALICETI, P., DE FILIPPIS, P., GIUNCHEDI, P., and LORA, S., J. Controlled Release, 1998, 52 (3), 227–237.
  • Preclinical pharm acology, toxicology, and effi cacy of sphingom yelin/cholesterol liposom al vincristine for therapeutic treatm ent of cancer. WE, M. S., LOGAN, P., KANTER, P. M., S. ONGE, G., GELMON, K., HARASYM, T., MAYER, L. D., and BALLY, M. B ., Cancer Chemother Pharmacol, 1998, 42 (6) 461–470.
  • Preparation and biodegradability of m icrosphere prepared from biodegradable m icrogel. Kr, K. S., KANG, S. H., and Kr, J. M., Kongop Hwahak, 1998, 9 (4) 591–594.
  • Preparation and characterization of echogenic liposom e as an ultrasound contrast agent: size-dependency and stabilizing effect of cholesterol on the echogenicity of gas-entrapping liposom e. KIMURA, A., SAKAI, A., TSUKISHIRO, S., BEPPU, S., and FUJIWARA, H., Chem. Pharm. Bull. (Tokyo), 1998, 46 (10), 1493–1496.
  • Preparation and tabletting of dipyridam ole alginate-Eudragit m icrospheres. GURSOY, A., KALKAN, F., and OKAR, I., J. Microencapsul., 1998, 15 (5), 621–628.
  • Preparation and characterization of beta-cyclodextrin and poly (acrylic acid) m icrospheres. BIBBY, D. C., DAVIES, N. M., and TUCKER, I. G., J. Microencapsul., 1998, 15 (5), 629-637. Preparation of silica m icrocapsules by sol-gel method in W/O em ulsion. ONO, H., and TAxAnAsnI, K., J. Chem. Eng. Jpn., 1998, 31 (5) 808–812.
  • Preparation and characterization of nanoparticles containing an antihypertensive agent. LEROUEIL, L. V. M., FLUCKIGER, L., KID, Y. I., HOFFMAN, M., and MAINCENT, P., Eur. J. Pharm. Biopharm., 1998, 46 (2), 137–143.
  • Preparation and characterization of enteric m icrospheres containing bovine insulin by a w /o/w em ulsion solvent evaporation method. NAGAREYA, N., UcnIuA, T., and M —ATSUYAMA, K., Chem. Pharm. Bull., 1998, 46 (10), 1613–1617.
  • Preparation and in vitro release studies of ibuprofen-loaded films and m icrospheres made from graft copolym ers of poly(L-lactic acid) on acrylic backbones. GALLARDO, A., EGUIBURU, J L., FERNANDEZ-BERRIDI, M. j., and SAN, R. J., J. Controlled Release, 1998, 55 (2, 3), 171–179.
  • Preparation and testing of cyclosporine m icrosphere and solution form ulations in the treatm ent of polyarthritis in rats. D'SouzA, M., and DESouzA, P., Drug Dev. Ind. Pharm., 1998, 24 (9), 841–852.
  • Preparation and characterization of m elatonin-loaded stearyl alcohol m icrospheres. LEE, B J., CHOE, J. s., and Kr, C, K., J. Microencapsulation, 1998, 15 (6), 775–787.
  • Preparation and characterization of oil-in-w ater type poly(DL-lactic acid) m icrospheres containing testosterone enanthate. Tsuauxu, S., Sucwwwlaw, S., MIYAJIMA, M., YOSHIDA, M., ASANO, M., °KASE, K., KoswVASHI, D., and YAMANAKA, H., Drug Dev. Ind. Pharm., 1998, 24 (10), 927–934.
  • Preparation of unilam ellar fusogenic liposom es using the Sendai virus. NAKANISHI, M., and MIZUGUCHI, H., Nippon Yakurigaku Zasshi, 1998, 112 (5), 299–305.
  • Preparation of m onodisperse crosslinked polystyrene m icrospheres for the packing materials of HPLC. Sul, X., Hut, H., and TIAN, B., Hecheng Huaxue, 1998, 6 (3), 302–306.
  • Preparation and evaluation of liposom es containing epirubicin. AcwI., M., and LEUCUTA, S. E., Clujul. Med., 1998, 71 (1), 88–94.
  • Preparation of adriam ycin liposom es by a pH-gradient m ethod. DENG, Y., Yu, B., LI, H., and Gu, X., Shenyang Yaoke Daxue X uebao, 1997, 14 (4), 239–242.
  • Preparation of silica m icrocapsules containing UV-shielding materials and their shielding ability. KUROKI, 0., MIZUGUCHI, M., NOGUCHI, M., and KAMATA, S., Shikizai Kyokaishi, 1998, 71 (8), 488–493.
  • Preparation of sodium heparin gelatin m icrospheres. Lu, W., WANG, L., and L, c., Zhongguo Shenghua Yaowu Zazhi, 1998, 19 (3), 136–138.
  • Preparation, characterization and in vitro antim icrobial activity of am picillin-loaded poly-ethylcyanoacrylate nanoparticles. FONTANA, G., PITARRESI, G., TOMARCHIO, V., CARLISI, B., and SAN-BIAGIO, P. L., Biomaterials, 1998 19 (11, 12), 1009–1017.
  • Proanthocyanidin m icrocapsules: preparation, properties and free radical scavenging activ-ity. ANDRY, M. C., VEZIN, H., DUMISTRACEL, I., BERNIER, J. L., and LEVY, M, C., Int. J. Pharm., 1998, 171 (2), 217–226.
  • Production of m icroparticles by high-pressure hom ogenization. CALVOR, A., and M -ULLER, B. W
  • Pharm. Dev. Technol., 1998, 3 (3), 297–305.
  • Prolonged intercostal nerve blockade in sheep using controlled-release of bupivacaine and dexam ethasone from polymer m icrospheres. DRAGER, C., BENZIGER, D., GAO, F., and BERDE, C. B., Anesthesiology, 1998, 89 (4), 969–979.
  • Properties of sol-gel-prepared glass m icrospheres for medical use. QIAN, D., Zxou, N., Wu, Z., and HUG, W., Boli Yu Tangci, 1998, 26 (2), 12–16.
  • Protein encapsulation within polyethylene glycol, coated nanospheres. I. Physicochem ical characterization. QUELLEC, P., GREF, R., PERRIN, L., DELLACHERIE, E., SOMMER, F., VERHAVATZ, J. m., and ALONSO, M. j., J. Biomed. Mater. Res., 1998, 42 (1), 45–54.
  • Proteoglycans m ediate cationic liposom e-DNA com plex-based gene delivery in vitro and in vivo. MOUNKES, L. C., ZHONG, W., CIPRES, P. G., HEATH, T. D., and HESS, R. j., J. Biol. Chem., 1998, 273 (40), 26164–26170.
  • Pulm onary delivery of nanoparticles of insoluble, iodinated CT X-ray contrast agents to lung draining lym ph nodes in dogs. MCINTIRE, G. L., BACON, E. R., TONER, J. L., CORNACOFF, J. B., Losco, P. E., ILLIG, K. J. NIKULA, K. J., MUGGENHURG, B. A., and KETAI, L., J. Pharm. Sci., 1998, 87 (11), 1466–1470.
  • Quantitative analysis of modified antisense oligonucleotides in biological fluids using cationic nanoparticles for solid-phase extraction. GERSTER, M., SCHEWITZ, J,, FRITZ, H., MAIER, M., and BAYER, E., Anal. Biochem., 1998, 262 (2), 177–184.
  • Radioactively labeled liposom es. MAGuLovw, D., CHALAHALA, M., and KOMAREK, P., Farm. Obz., 1998, 67 (11), 285–288.
  • Rats receiving the slimming agent oleoyl-estrone in liposom es (Merlin-2) decrease food intake but maintain therm ogenesis. SANCHIS, D., BALwow, F., Plc°, C., GRASA, M. M., VIRGILI, J., FARRERONS, C., PALOU, A., FERNANDEZ, L. J. A., REMESAR, x., and ALEMANY, M., Arch. Physiol. Biochem., 1997, 105 (7), 663–672.
  • Recent progress in research on immobilization of microorganisms and animal cells on m icrocapsules. M., L., and Yo, S., X iandai Huagong, 1998, 18 (1), 19–22.
  • Reconstructed hum an skin as model for liposom e-skin interaction. ZELLMER, S., REISMG, D., and LAscu, j., J. Controlled Release, 1998, 55 (2, 3), 271–279.
  • Reduction of skin flap necrosis by transderm al application of buflom edil bound to liposom es. Dn. E., ROSKEN, F., Cull., S. B., MENGER, M. D., MESSMER, K., Plast. Reconstr. Surg., 1998, 102 (5), 1598–1604.
  • Regional haem odynam ic differences between norm otensive and spontaneously hyperten-sive rats-a m icrosphere study. GRANSTAM, S. 0., GRANSTAM, E., FELLSTROM, B., and LIND, L., Physiol. Res., 1998, 47 (1), 9–15.
  • Relationship between physicochem ical characteristics of plasm id DNA-cationic liposom e corn plexes and their gene expression effi ciency. SAKURAI, F., NISHINO, Y., Oxuow, A., MATSUMOTO, 0., TAGAL, T., TAKAKURA, Y., and HAsutuA, M., Nucleic Acids Symp. Ser., 1998, 39, 73–74.
  • Release of enzymes from liposom es during cheese ripening. LALOY, E., VUILLEMARD, J. C., DUFOUR, P. and SIMARD, R., J. Controlled Release, 1998, 54 (2), 213–222.
  • Research progress of m agnetic polymer m icrospheres. WANG, Y., and FENG, L., Gaofenzi Cailiao Kexue Yu Gongcheng, 1998, 14 (5), 6–8. 14.
  • Reversal of hyperglycem ia in streptozotocin diabetic mice by xenotransplantation of micro-encapsulated rat islets. TATARKIEWICZ, K., SITAREK, E., SADAT, M., and ORLOWSKI, T., Ann. Transplant, 1997, 2 (2), 20–23.
  • Rheological and fireproofing characteristics of polyethylene modified with a m icroencapsu-lated fire retardant. Zurmovw, N. S., BUTYLKINA, N. G., CHEKANOVA, S. E., TYUGANOVA, M. A., KHALTURINSKII, N. A., RESHETNIKOV, I. S., and NAGANOVSKII, Yu. K., Fibre Chem., 1998, 30 (1), 11–13.
  • Safety, tolerance, and pharm acokinetics of a small unilam ellar liposom al form ulation of am photericin B (Am Bisom e) in neutropenic patients. WwLsir, T. T V - ELDANDI, V., McEvoy, M., GONZALEZ, C., CHANOCK, S., FREIFELD, A., SEIHEL, N. I., WHITCOMB, P. 0., JAROSINSKI, P., BOSWELL, G., BEKERSKY, I., ALAN, A., BUELL, D., BASSET, j., and WILSON, W Antimicrob. Agents Chemother., 1998, 42 (9), 2391–2398.
  • Self-assem bled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: corn plexation and stabilization of insulin. AKIVOSHI, K., KOBAYASHI, S., SHICHIBE, S., MIX, D., BAUDYS, M., KIM, S. w., and SUNAMOTO, J., J. Controlled Release, 1998, 54 (3), 313–320.
  • Single-m olecule visualization of interaction between DNA and oppositely charged m ixed liposom es. MEL, N. S. M., MEL, N. Y. S., and LOEFROTH, J. E., J. Phys. Chem B., 1998, 102 (47), 9367–9369.
  • Solid lipid nanoparticles (SLN) for controlled drug delivery—drug release and release mechanism. ZUR MUHLEN, A., SCHWARZ, C., and MEHNERT, W Eur. J. Pharm. Biopharm., 1998, 45 (2), 149–155.
  • Spray-drying of solid lipid nanoparticles (SLN TM). FREITAS, C., and MULLERA, R, H., Eur. J. Pharm. Biopharm., 1998, 46 (2), 145–151.
  • Statistical experim ental design based studies on placebo and m itoxantrone-loaded album in m icrospheres. LUFTENSTEINER, C. P, and VIERNSTEIN, H., Int. J. Pharm., 1998, 171 (1), 87–99.
  • Sterically stabilized liposom es of DPPC/DPPE-PEG:2000. A spin label ESR and spectrophoto-m etric study. BELSITO, S., BARTUCCI, R., and SPORTELLI, L., Biophys. Chem., 1998, 75 (1), 33–43.
  • Studies in liposom e-encapsulated indom ethacin. Goir.r, M. C, GOPI, S., and TIWARI, S., B., Indian Drugs, 1998, 35 (8), 503–508.
  • Studies on the im m une effect of thym osin-liposom e. LI, H., LI, Y., Cwo, C., DENG, Y., LI, S., and ZHENG, W., Shenyang Yaoke Daxue X uebao, 1998, 15 (2), 102–105.
  • Study on synthesis of self cross-linked polystyrene latex m icrospheres. DA,, L., Zoo, Y., Fu, X., and HONG, M., Chin. J. React Polyn., 1997, 6 (1, 2), 43–48.
  • Study on the encapsulation of protein in biodegradable polymer m icrospheres. LI, X.,Xiwo, J., NioNG, C., DENG, X., JIA, W., MENG, L., and ZHENG, Z., Gaofenzi Cailiao Kexue Yu Gongcheng, 1998, 14 (4), 93–96.
  • Study on the m itoxantrone ethylcellulose m icrospheres for liver artery em bolization. ZHANG, Z. R., WANG, D., LIwo, F. Y., and LIwo, G, T., Yao Hsueh Hsueh Pao, 1996, 31 (8), 626–631.
  • Study on nickel-m icroencapsulation of hydrogen-storage alloy. COON, Q., WANG, Z., LI, X., Guop B., and LILT j., Zhongguo Y ouse Jinshu X uebao, 1998, 8 (3), 477–481.
  • Study on preparation of capsules of m icroencapsulated fish oil. TANG, H., Zuwo, Y., ZHANG, X., Zoo, j., and LIAO, N., Zhongguo Y iyuan Yaoxue Zazhi, 1998, 18 (1), 25–26.
  • Successful treatm ent of invasive aspergillosis in chronic granulom atous disease by bone marrow transplantation, granulocyte colony-stim ulating factor-m obilized granulo-cytes, and liposom al am photericin-B. OZSAHIN, H.,V ON - P LANTA, M., MULLER, I., STEINERT, H. C., NASAL, D., LAUENER, R., TUCHSCHMID, P., WILLI, U. V., OZSAHIN, M., CROMPTON, N. E. A., and SEGER, R. A., Blood, 1998, 92 (8), 2719–2724.
  • Sulfated zirconia spheres and m icrospheres by gel supported precipitation. PINNA, F., SCARPA, M., SIGNORETTO, M., STRUKUL, G., MARELLA, M., TOMASELLI, M., MEREGALLI, L., and SCATTOLIN, R., Stud. Surf. S ci. Catal., 1998, 118 (Preparation of Catalysts VII), 625–632.
  • Sustained cytokine delivery for anticancer vaccination: liposom es as alternative for gene-transfected turn or cells. KOPPENHAGEN, F. J., KUEPCUE, Z., WALLNER, G., CROMMELIN D. J. A., WAGNER, E., STORM, G., and KIRCHEIS, R., Clin. Cancer Res., 1998, 4 (8), 1881–1886.
  • Synthesis of therm °sensitive magnetic polymer m icrospheres. DING, X., SUN, Z., WAN, G., and jIANG, Y., Gaofenzi Zuebao 1998, (5), 628–631.
  • Targeting liposom es through im m unoglobulin superfam ily dom ains: PO protein as a m od el. FOLDVARI, M., JAAFARI, M. R., MEZEI, M., and MEZEI, C., Drug Delivery, 1998, 5 (3), 183–195.
  • The capacity of a corn bined liposom al hepatitis B and C vaccine to stim ulate hum oral and cellular responses in mice. KILEMKA, V., SEE, D., SEE, J., CHANG, J., CHOU, S., and TILLES, J., Viral Immunol., 1998, 11 (2), 73–78.
  • The control of protein release from poly(DL-lactide co-glycolide) m icroparticles by variation of the external aqueous phase surfactant in the water-in oil-in water m ethod. CoomaEs, A. G., YEH, M. K., LAVELLE, E. C., and DAVIS, S. S., J. Controlled Release, 1998, 52 (3), 311–320.
  • The dependence of membrane perm eability by the antibacterial peptide cecropin B and its analogs, CB-1 and CB-3, on liposom es of different com position. WANG, W., SMITH, D. K., MOULDING, K., and CHEN, H, M., J. Biol. Chem., 1998, 273 (42), 27438–27448.
  • The effect of core-to-w all ratio and Span 80 concentration on the properties of ascorbic acid m icrocapsules. VANICHTANUNKUL, D., VAYUMILASUWAN, P., and NIMMANNIT, U., J. Microencapsulation, 1998, 15 (6), 753–759.
  • The effects of godulbaegi extracts on the fluidity of phospholipid liposom es by DSC. BAs, S. J., Klm, N. H., Ron, S. B., and JUNG, B. M., Han'guk Sikp'um Y ongyang Kwahak Hoechi, 1998, 27 (3), 518–524.
  • The effects of pH and intraliposom al buffer strength on the rate of liposom e content release and intracellular drug delivery. L.., R. J., WANG, S., TURN, M. j., and Low, P. S., 1998, Biosci. Rep., 18 (2), 69–78.
  • The nucleation and growth of calcium phosphate crystals at protein and phosphatidylserine liposom e surfaces. NANCOLLAS, G. H., TSORTOS, A, and ZIEsw, A., Scanning Microsc., 1996, 10 (2), 499–507; discussion 508.
  • The physical and chem ical stability of suspensions of sustained-release diclofenac m icro-sph eres. LEWIS, L., BONI, R. L., and ADEVEYE, C. M., J. Microencapsul., 1998, 15 (5), 555–567.
  • The use of cardiac biopsy to dem onstrate reduced cardiotoxicity in AIDS Kaposi's sarcom a patients treated with pegylated liposom al doxorubicin. BERRY, G., BILLINGHAM, M., ALDERMAN, E., RICHARDSON, P., TORT, F., Lum, B., PATEK, A., and MARTIN, F. J., Ann. Oncol., 1998, 9 (7), 711–716.
  • The immunological co-adjuvant action of liposom al interleukin-15. GURSEL, M., and GREGORIADIS, G., NATO ASI Ser. Ser. A., 1997, 293 (Vaccine Design), 175–180.
  • Tim e-dependent changes in the ischem ic forebrain following the m icrosphere-induced perm anent occlusion of cerebral arterioles in rats. OKUYAMA, K., KIucHI, S., OKAMOTO, M., IWASAKI, H., NARITA, H., and KUDO, Y., Jpn. J. Pharmacol., 1998, 78 (1), 31–37.
  • Titanium dioxide hollow m icrospheres with an extrem ely thin shell. IIDA, M., SwswEI, T., and WATANABE, M., Chem. Mater., 1998, 10 (12), 3780–3782.
  • Transfection of cultured m yoblasts in high serum concentration with DODAC:DOPE lipo-som es. VITIELLO, L., BOCKHOLD, K,. JosnI, P. B., and WORTON, R. G., Gene. T her., 1998, 5 (10), 1306–1313.
  • Transform ation of a liposom al dispersion containing ibuprofen lysinate and phospholipids into mixed micelles — physico-chemical characterization and influence on drug perm eation through excised hum an stratum corneum. STOVE, I., SCHRODER, K., and MULLER, G. C. C., Eur. J. Pharm. Biopharm., 1998, 46 (2), 191–200.
  • Treatm ent of large solid tum ors in mice with daunom ycin-loaded sterically stabilized liposom es. GOLDEN, P. L., HUWYLER, j., and PARDRIDGE, W. M., Drug Delivery, 1998, 5 (3), 207–212.
  • Ultrasound contrast agents: the advantage of album in m icrosphere technology. JABLONSKI, E. G., DITTRICH, H. C., BARTLETT, J. M., and PODELL, S. B., Rev. Prog. Quant. Nondesr Eval., 1998, 17A, 15–22.
  • Ultrasound-induced degradation of PLA and PLGA during m icrosphere processing: influ-ence of form ulation variables. REICH, G., Eur. J. Pharm. Biopharm., 1998, 45 (2), 165–171.
  • Ultrastructural characterization of cationic liposom e-DNA com plexes showing enhanced stability in serum and high transfection activity in vivo. STERNBERG, B., HONG, K., ZHENG, W., and PAPAHADJOPOULOS, D., Biochim. Biophys. Acta, 1998, 1375 (1, 2), 23–35.
  • Use of a liposom e antigen delivery system to alter immune responses in vivo. LUTSIAK, C. M. E., SOSNOWSKI, D., L, WIsnwrur, D. S., Kwox, G. S, and SAMUEL, J., J. Pharm. S ci., 1998, 87 (11), 1428–1432.
  • Use of m icrosphere technology for targeted delivery of rifam pin to Mycobacterium tuber-culosis-infected m acroph ages. BARROW, E. L. W., WINCHESTER, G. A., STAAS, J. K., QUENELLE, D. C., and BARROW, W. W., Antimicrob. Agents Chemother., 42 (10), 2682-2689.
  • Use of nonautologous m icroencapsulated fibroblasts in growth horm one gene therapy to improve growth of midget swine. CHENG, W. T. K., CHEN, B. C., CHlou, S. T., and CORN, C. M., Hum. Gene T her., 1998, 9 (14), 1995–2003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.